Cargando…

Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT(3) receptor antagonists

PURPOSE: The ferret cisplatin emesis model has been used for ~30 years and enabled identification of clinically used anti-emetics. We provide an objective assessment of this model including efficacy of 5-HT(3) receptor antagonists to assess its translational validity. METHODS: A systematic review id...

Descripción completa

Detalles Bibliográficos
Autores principales:	Percie du Sert, N., Rudd, J. A., Apfel, C. C., Andrews, P. L. R.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043247/ https://www.ncbi.nlm.nih.gov/pubmed/20509026 http://dx.doi.org/10.1007/s00280-010-1339-4

Ejemplares similares

Gastric myoelectric activity during cisplatin-induced acute and delayed emesis reveals a temporal impairment of slow waves in ferrets: effects not reversed by the GLP-1 receptor antagonist, exendin (9-39)
por: Lu, Zengbing, et al.
Publicado: (2017)

The involvement of TRPV1 in emesis and anti-emesis
por: Rudd, John A, et al.
Publicado: (2015)

Machine learning prediction of emesis and gastrointestinal state in ferrets
por: Nanivadekar, Ameya C., et al.
Publicado: (2019)

Differential hypoglycaemic, anorectic, autonomic and emetic effects of the glucagon-like peptide receptor agonist, exendin-4, in the conscious telemetered ferret
por: Lu, Zengbing, et al.
Publicado: (2014)

Cisplatin induced emesis: preliminary results indicative of changes in plasma levels of 5-hydroxytryptamine.
por: Barnes, N. M., et al.
Publicado: (1990)

Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT(3) Antagonist, Palonosetron and With the NK(1) Antagonist, Netupitant, Against Cisplatin- and Motion-Induced Emesis in Suncus murinus (House Musk Shrew)
por: Rudd, John A., et al.
Publicado: (2018)

Effects of 5‐HT(₃) receptor antagonists on cisplatin‐induced kidney injury
por: Goda, Mitsuhiro, et al.
Publicado: (2021)

Corrigendum: Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT(3) Antagonist, Palonosetron and With the NK(1) Antagonist, Netupitant, Against Cisplatin- and Motion-Induced Emesis in Suncus murinus (House Musk Shrew)
por: Rudd, John A., et al.
Publicado: (2018)

Gingerol inhibits cisplatin-induced acute and delayed emesis in rats and minks by regulating the central and peripheral 5-HT, SP, and DA systems
por: Tian, Li, et al.
Publicado: (2019)

Dexamethasone can potentiate the anti-emetic action of a 5HT3 receptor antagonist on cyclophosphamide induced vomiting in the ferret.
por: Hawthorn, J., et al.
Publicado: (1990)

Correction to: Gingerol inhibits cisplatin-induced acute and delayed emesis in rats and minks by regulating the central and peripheral 5-HT, SP, and DA systems
por: Tian, Li, et al.
Publicado: (2020)

Nephrotoxicity Evaluation on Cisplatin Combined with 5-HT(3) Receptor Antagonists: A Retrospective Study
por: Kou, Wen, et al.
Publicado: (2018)

Evaluating the various phases of cisplatin-induced emesis in rats
por: SHI, JUN
Publicado: (2014)

Ondansetron compared with ondansetron plus metoclopramide in the prevention of cisplatin-induced emesis.
por: Lee, C. W., et al.
Publicado: (1994)

Azologization of serotonin 5-HT(3) receptor antagonists
por: Rustler, Karin, et al.
Publicado: (2019)

The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT(3) receptors
por: Lochner, Martin, et al.
Publicado: (2016)

The importance of systematic approaches in the study of emesis
por: De Jonghe, Bart C, et al.
Publicado: (2015)

5-HT3 receptor antagonists for the prevention of postoperative shivering: a meta-analysis
por: Zhou, Chengmao, et al.
Publicado: (2016)

Randomised trial for the prevention of delayed emesis in patients receiving high-dose cisplatin.
por: Matsui, K., et al.
Publicado: (1996)

Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats
por: Fijał, Katarzyna, et al.
Publicado: (2013)

Agonists and antagonists induce different palonosetron dissociation rates in 5-HT(3)A and 5-HT(3)AB receptors()
por: Lummis, Sarah C.R., et al.
Publicado: (2013)

5HT6 Antagonists in the Treatment of Alzheimer’s Dementia: Current Progress
por: Andrews, Megan, et al.
Publicado: (2018)

Insights Into Acute and Delayed Cisplatin-Induced Emesis From a Microelectrode Array, Radiotelemetry and Whole-Body Plethysmography Study of Suncus murinus (House Musk Shrew)
por: Tu, Longlong, et al.
Publicado: (2021)

Effects of nicotine on gastric myoelectrical activity in ICR mice
por: Wang, Eileen Hui-Chuan, et al.
Publicado: (2012)

Constitutively Active 5-HT Receptors: An Explanation of How 5-HT Antagonists Inhibit Gut Motility in Species Where 5-HT is Not an Enteric Neurotransmitter?
por: Spencer, Nick J.
Publicado: (2015)

A Dunnione Compound MB12662 Improves Cisplatin-Induced Tissue Injury and Emesis
por: Park, Dongsun, et al.
Publicado: (2015)

Rare causes of emesis
por: Popa, Stefan L., et al.
Publicado: (2020)

Emesis in a Horse
por: Lowe, William Herbert
Publicado: (1884)

Role of 5-HT(2A) receptor antagonists in the treatment of insomnia
por: Vanover, Kimberly E, et al.
Publicado: (2010)

Existence of Brain 5-HT1A–5-HT2A Isoreceptor Complexes with Antagonistic Allosteric Receptor–Receptor Interactions Regulating 5-HT1A Receptor Recognition
por: Borroto-Escuela, Dasiel O., et al.
Publicado: (2017)

5-HT1A agonists, 5-HT3 antagonists and benzodiazepines : their comparative behavioural pharmacology /
Publicado: (1991)

CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine
por: Capi, Matilde, et al.
Publicado: (2021)

Improving the reporting of animal research: when will we ARRIVE?
por: Percie du Sert, Nathalie
Publicado: (2011)

Serotonin 5-HT3 Receptor Antagonist for Treatment of Severe Diabetic Diarrhea
por: Murao, Satoshi, et al.
Publicado: (2010)

Distribution of cells responsive to 5-HT(6) receptor antagonist-induced hypophagia
por: Garfield, Alastair S., et al.
Publicado: (2014)

Recent advances in antiemetics: new formulations of 5HT(3)-receptor antagonists
por: Gilmore, James, et al.
Publicado: (2018)

Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis.
por: Miner, W. D., et al.
Publicado: (1987)

5-Hydroxyindoleacetic acid (5-HIAA) and cortisol excretion as predictors of chemotherapy-induced emesis.
por: du Bois, A., et al.
Publicado: (1996)

5-HT3 and 5-HT4 antagonists inhibit peristaltic contractions in guinea-pig distal colon by mechanisms independent of endogenous 5-HT
por: Sia, Tiong C., et al.
Publicado: (2013)

Comparative safety of serotonin (5-HT(3)) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis
por: Tricco, Andrea C, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lbkp9q4umsq2vflnj75mrfk011